Baricitinib for the treatment of atopic dermatitis

Baricitinib for the treatment of atopic dermatitis

Atopic dermatitis is a common, chronic and recurrent inflammatory skin disease, which often appears in childhood but can last into adulthood. It negatively impacts patients, their families and society in general. There is a therapeutic unmet need, with patients requiring new drugs that are safe and...

Full description

Bibliographic Details
Main Authors: Amelia Melo, Jose Manuel Carrascosa, Tiago Torres
Format: Article
Language:English
Published: Taylor & Francis Group 2022-07-01
Series:Journal of Dermatological Treatment
Subjects:
atopic dermatitis
baricitinib
jak inhibitors
jak/stat
Online Access:http://dx.doi.org/10.1080/09546634.2021.1967268

Similar Items

Similar Items